Is an insulin-like growth factor-1 (IGF-1) level of 49 µg/L in a 15-month-old toddler within the normal reference range?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IGF-1 Level of 49 µg/L in a 15-Month-Old Toddler

An IGF-1 level of 49 µg/L (49 ng/mL) in a 15-month-old toddler has limited clinical utility and should not be used to determine normalcy, as IGF-1 is unreliable for assessment in children under 18 months of age. 1

Why IGF-1 Cannot Be Interpreted at This Age

The most recent pediatric endocrinology guidelines explicitly state that IGF-1 levels have limited utility within the first 18 months of life because they are significantly impacted by multiple non-pathological factors 1:

  • Weight gain and adiposity status
  • Type of feeding (breast milk vs. formula)
  • Maternal smoking exposure
  • Nutritional status

These confounding variables make it impossible to establish whether a given IGF-1 value represents normal physiology or pathology in this age group.

What Should Be Used Instead

For children up to 3 years of age, IGFBP-3 (IGF Binding Protein-3) levels are a better screening biomarker than IGF-1 1. If growth hormone deficiency is suspected in a toddler this age, the diagnostic approach should include:

  • IGFBP-3 measurement rather than relying on IGF-1
  • Auxologic assessment: Growth velocity, height/length tracking on growth charts, comparison to mid-parental height
  • Bone age assessment if growth failure is present
  • Random GH level (if under 28 days old, a level ≤5 µg/L plus other pituitary hormone deficiencies is diagnostic) 1

Reference Data Context

While research studies have measured IGF-1 in healthy toddlers 2, 3, showing mean values around 75.9 ± 36.1 ng/mL at 12 months 2, these population-based reference ranges cannot be applied clinically to individual patients under 18 months due to the high inter-individual variability from the confounding factors mentioned above.

Clinical Pitfall to Avoid

Do not attempt to diagnose or exclude growth hormone deficiency based on IGF-1 alone in a 15-month-old child. The guideline evidence is clear that this biomarker lacks specificity and sensitivity in this age group 1. If there are clinical concerns about growth, proceed with IGFBP-3 testing and comprehensive auxologic evaluation rather than interpreting this IGF-1 value.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.